Shopping Cart
- Remove All
Your shopping cart is currently empty
Avizakimab (BOS161721) is a humanized lgG1 monoclonal antibody that targets and inhibits the biological activity of IL-21, with potential for the treatment of systemic lupus erythematosus (SLE).
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $290 | In Stock | |
| 5 mg | $723 | In Stock | |
| 10 mg | $986 | In Stock | |
| 25 mg | $1,490 | In Stock | |
| 50 mg | $1,970 | In Stock |
| Description | Avizakimab (BOS161721) is a humanized lgG1 monoclonal antibody that targets and inhibits the biological activity of IL-21, with potential for the treatment of systemic lupus erythematosus (SLE). |
| In vitro | In vitro, Avizakimab blocks IL-22 binding to IL-22R1 and inhibits downstream STAT3 phosphorylation[1]. |
| Synonyms | BOS161721, BOS 161721 |
| Cas No. | 2229685-51-0 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.